New drugs may make a dent in lung, ovarian cancer
For the first time in a decade, an experimental drug has extended the life of patients with advanced lung cancer who relapsed after standard chemotherapy.
But the benefit in the study was so small — six extra weeks, on average — that it is raising fresh questions about the value of some costly new cancer medicines.
Eli Lilly and Co.’s drug Cyramza was tested in more than 1,200 patients. It is sold now for stomach cancer and costs $6,000 per infusion.
The study was discussed Saturday at a cancer conference in Chicago where doctors also reported progress with new drugs against relapsed ovarian cancer and chronic lymphocytic leukemia, the most common type of leukemia in adults.
WHYY is your source for fact-based, in-depth journalism and information. As a nonprofit organization, we rely on financial support from readers like you. Please give today.
As beachgoers start heading down the shore, we look at new sea level rise projections that put much of New Jersey's coastline underwater in the coming decades.
Air Date: May 14, 2024 12:00 pm
One natural gas transport plan killed in New Jersey as another forges ahead
A pipeline that would move natural gas through the state and to N.Y. has been killed. But another plan to transport liquefied gas from Pa. by tanker truck is moving forward.
1 week ago
Villanova University rain garden shows 20-year success at soaking up stormwater runoff
The school's rain gardens have proven effective at helping prevent raw sewage from overflowing into waterways.
1 week ago
Listen 1:17